FIELD: organic chemistry, medicine, biochemistry.
SUBSTANCE: invention relates to new compounds of the formula (I) wherein R1 and R2 can be similar or different and represent independently (C1-C6)-alkyl that are selective inhibitors of enzyme phosphodiesterase, and to their pharmaceutically acceptable salts or stereoisomers. Also, invention involves a method for preparing the preferable compound, i. e. 5-[[2-ethoxy-5-(cis-2,6-dimethylpiperazin-4-ylsulfonyl)phenyl]]-1-methyl-3-n-propyl-7,6-dihydro-1H-pyrazolo[4,3-d]pyrimidine-7-one. Also, invention proposes new intermediate compounds used in method for synthesis of this compound. Compounds of the formula (I) show very high effectiveness in treatment of diseases associated with impotence, such as the male erectile sterility but they exhibit such features as prolonged therapeutic effectiveness and lower toxicity. Also, invention relates to a pharmaceutical composition used in treatment of impotence and using compound of the formula (I) in preparing the medicinal preparation designated for treatment of diseases associated with impotence.
EFFECT: valuable medicinal properties of compound.
8 cl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF PYRROLOPYRIMIDINE, METHOD FOR PREPARING AND THEIR USING | 2001 |
|
RU2263676C2 |
IMPROVED METHOD FOR PREPARING 5-[2-ETHOXY-5-(4-METHYLPIPERAZIN-1-YLSULFONYL)PHENYL]-1-METHYL-N-PROPYL-1, 6-DIHYDRO-7H-PYRAZIL[4,3-D]PYRIMIDINE-7-ONE | 2003 |
|
RU2239637C1 |
METHOD OF SYNTHESIS OF PYRAZOLOPYRIMIDINE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1991 |
|
RU2047617C1 |
PYRAZOLOPYRIMIDINONES, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF CYCLIC GUANOSINE-3',5'-MONOPHOSPHATE PHOSPHODIESTERASE | 1992 |
|
RU2114113C1 |
PYRAZOLOPYRIMIDINONE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1991 |
|
RU2114114C1 |
NEW PHARMACEUTICAL COMPOSITIONS FOR SEXUAL DISORDERS | 2005 |
|
RU2445095C2 |
SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITOR | 2014 |
|
RU2671212C2 |
UBIQUITIN-SPECIFIC PROTEASE 7 PROTEIN INHIBITOR MOLECULES | 2022 |
|
RU2814272C1 |
DERIVANTS OF 2, 4, 5-TRIPHENYLIMIDAZOLINE AS INACTIVATORS OF INTERACTION BETWEEN P53 AND MDM2 PROTEINS DESIGNED FOR APPLICATION AS ANTICANCER DRUGS | 2006 |
|
RU2442779C2 |
NOVEL 1,2-BIS-SULPHONAMIDE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR | 2011 |
|
RU2654213C9 |
Authors
Dates
2006-07-10—Published
2002-06-21—Filed